Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HepaStem Long-Term Safety Registry - Registry for Patients Who Have Been Administered HepaStem

NCT03343756 is registered in ClinicalTrials.gov with Cellaion SA as lead sponsor.

NCT NCT03343756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03343756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HepaStem Long-Term Safety Registry - Registry for Patients Who Have Been Administered HepaStem
Lead sponsor
Cellaion SA
Phase
Observational
Overall status
Terminated
Start date
April 4, 2018
Completion date
May 23, 2024
Enrollment
44 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

acute on chronic liver failure, crigler-najjar syndrome, urea cycle disorder